Delivery Order SPE2DR25D6044-SPE2DR26FYB1B
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,425.07 to AmerisourceBergen Drug Corp for ACT-O-VIALS on January 20, 2026, with an ultimate completion date of January 21, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under full and open competition. The contractor, headquartered in Conshohocken, Pennsylvania, is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal government healthcare systems....
- The Defense Logistics Agency awarded a delivery order valued at $1,328.10 to AmerisourceBergen Drug Corp for Act-O-Vials, with an ultimate completion date of December 1, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen...
- On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,425.07 to AmerisourceBergen Drug Corp for ACT-O-VIALS, with an ultimate completion date of January 14, 2026. This is a firm fixed-price delivery order issued under a competitive process with no set-aside designation. The awardee, AmerisourceBergen Drug Corp, is headquartered in Conshohocken, Pennsylvania, and serves as a critical pharmaceutical distributor to federal medical procurement programs, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $13,080.36 to AmerisourceBergen Drug Corp for Act-O-Vials on January 15, 2026, with a completion date of January 16, 2026. This firm fixed-price delivery order carries no set-aside designation, indicating it was awarded through open competition. The contractor, headquartered in Conshohocken, Pennsylvania, is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen) and serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $6,813.71 to AmerisourceBergen Drug Corp for ACT-O-VIALS, effective January 5, 2026, with completion by January 6, 2026. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order is being fulfilled from the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,328.32 to AmerisourceBergen Drug Corp for Act-O-Vials on December 23, 2025, with completion targeted for December 24, 2025. This competitively awarded, non-set-aside delivery order operates under a firm fixed price structure and is part of AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $6,860.20 to AmerisourceBergen Drug Corp for Act-O-Vials pharmaceutical products on September 17, 2025, with completion expected by September 18, 2025. This firm fixed-price contract, issued without a set-aside designation, represents a competitively awarded order for medical supplies to support federal healthcare operations. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $2,407.80 to AmerisourceBergen Drug Corp on January 8, 2026, for Act-O-Vials pharmaceutical supplies. This firm fixed-price contract, with an ultimate completion date of January 9, 2026, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's proven capability to...
- The Defense Logistics Agency awarded a delivery order valued at $27,440.80 to AmerisourceBergen Drug Corp for Act-o-Vials on September 16, 2025, with completion targeted for September 17, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $1,992.15 delivery order to AmerisourceBergen Drug Corp for ACT-O-Vials on December 10, 2025, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate...
- SPE2DR25D6044Indefinite Delivery Contract
- SPE2DR25D6044-SPE2DR26FYB1BDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,425.07 to AmerisourceBergen Drug Corp for Act-O-Vials on February 2, 2026, with an ultimate completion date of February 3, 2026. This contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded under full and open competition. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor and healthcare solutions provider specializing in supplying medical products to federal government agencies. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to meet the Defense Logistics Agency's medical procurement requirements across multiple therapeutic domains and customer bases, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 2/1/26 |